Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe PneumoniaOlivier Hermine, Robin Charreteur, Jacques Cadranel et al.|JAMA Internal Medicine|2020Cited by 777
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trialPierre‐Louis Tharaux, Robin Charreteur, Gilles Pialoux et al.|The Lancet Respiratory Medicine|2021Cited by 297
Continuous positive airway pressure for respiratory support during COVID-19 pandemic: a frugal approach from bench to bedsideGuillaume Carteaux, Armand Mekontso Dessap, Manuella Pons et al.|Annals of Intensive Care|2021Cited by 34
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trialsIlias Ι. Siempos, Lauren Demerville, André C. Kalil et al.|EClinicalMedicine|2024Cited by 8
Acid sphingomyelinase deficiency in France: a retrospective survival studyWladimir Mauhin, S. Trouillier, Nathalie Guffon et al.|Orphanet Journal of Rare Diseases|2024Cited by 7